Platelet-to-Lymphocyte ratio (PLR) as a predictive marker in HER2 positive metastatic breast cancer patients treated with first-line trastuzumab therapy.

	Platelet-to-Lymphocyte ratio (PLR) as a predictive marker in HER2 positive metastatic breast cancer patients treated with first-line trastuzumab therapy.
	Fang, Zi-Ru ; Shen, Xia-Bo ; Wu, Jia-Yi ; Chen, Ke-Yu ; Shao, Xi-Ying ; Wang, Xiaojia
刊名	JOURNAL OF CLINICAL ONCOLOGY
	2022-06-01
卷号	40
ISSN号	0732-183X
WOS研究方向	Oncology
语种	英语
出版者	LIPPINCOTT WILLIAMS & WILKINS
WOS记录号	WOS:000863680302558
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/129859]
专题	中国科学院合肥物质科学研究院
作者单位	1.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Dept Breast Med Oncol, Hangzhou, Peoples R China 2.Univ Chinese Acad Sci, Canc Hosp, Hangzhou, Peoples R China 3.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Peoples R China 4.Univ Chinese Acad Sci, Canc Hosp, Dept Med Oncol Breast, Zhejiang Canc Hosp, Hangzhou, Peoples R China 5.Chinese Acad Sci, Inst Canc & Basic Med IBMC, Hangzhou, Peoples R China
推荐引用方式 GB/T 7714	Fang, Zi-Ru,Shen, Xia-Bo,Wu, Jia-Yi,et al. Platelet-to-Lymphocyte ratio (PLR) as a predictive marker in HER2 positive metastatic breast cancer patients treated with first-line trastuzumab therapy.[J]. JOURNAL OF CLINICAL ONCOLOGY,2022,40.
APA	Fang, Zi-Ru,Shen, Xia-Bo,Wu, Jia-Yi,Chen, Ke-Yu,Shao, Xi-Ying,&Wang, Xiaojia.(2022).Platelet-to-Lymphocyte ratio (PLR) as a predictive marker in HER2 positive metastatic breast cancer patients treated with first-line trastuzumab therapy..JOURNAL OF CLINICAL ONCOLOGY,40.
MLA	Fang, Zi-Ru,et al."Platelet-to-Lymphocyte ratio (PLR) as a predictive marker in HER2 positive metastatic breast cancer patients treated with first-line trastuzumab therapy.".JOURNAL OF CLINICAL ONCOLOGY 40(2022).